Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
USP3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BBS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNAH17-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX1A-SULT1A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPCAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LETM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00482 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDI2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on